MA56551A - Procédés et intermédiaires pour la production de composés de diazaspiro-lactame - Google Patents
Procédés et intermédiaires pour la production de composés de diazaspiro-lactameInfo
- Publication number
- MA56551A MA56551A MA056551A MA56551A MA56551A MA 56551 A MA56551 A MA 56551A MA 056551 A MA056551 A MA 056551A MA 56551 A MA56551 A MA 56551A MA 56551 A MA56551 A MA 56551A
- Authority
- MA
- Morocco
- Prior art keywords
- diazaspirolactam
- intermediates
- compounds
- production
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865840P | 2019-06-24 | 2019-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56551A true MA56551A (fr) | 2022-04-27 |
Family
ID=74060351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056551A MA56551A (fr) | 2019-06-24 | 2020-06-23 | Procédés et intermédiaires pour la production de composés de diazaspiro-lactame |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12215114B2 (fr) |
| EP (2) | EP3986400B1 (fr) |
| CN (2) | CN114269338B (fr) |
| ES (1) | ES2991258T3 (fr) |
| MA (1) | MA56551A (fr) |
| TW (1) | TWI887245B (fr) |
| WO (1) | WO2020263848A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA56550A (fr) * | 2019-06-24 | 2022-04-27 | Naurex Inc | Formes solides de tert-butyl (s)-2-((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo -2, 5-diazaspiro[3,4]octane-5-carboxylate et leurs procédés de préparation |
| US12215114B2 (en) | 2019-06-24 | 2025-02-04 | Naurex Inc. | Processes and intermediates for producing diazaspiro lactam compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
| BRPI0918868B8 (pt) | 2008-09-18 | 2021-05-25 | Naurex Inc | compostos moduladores do receptor de nmda e composições compreendendo os mesmos |
| CA2898863A1 (fr) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Modulateurs spirolactames d'un recepteur nmda et leurs utilisations |
| CA2898861C (fr) | 2013-01-29 | 2021-07-20 | Naurex, Inc. | Modulateurs spirolactames d'un recepteur nmda et leurs utilisations |
| CN105026401A (zh) * | 2013-01-29 | 2015-11-04 | 诺雷克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| PH12015501596B1 (en) * | 2013-01-29 | 2023-12-06 | Aptinyx Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| US20140238699A1 (en) | 2013-02-22 | 2014-08-28 | Vetco Gray Inc. | Wellhead annulus seal having a wickered surface |
| EA201892657A1 (ru) * | 2016-05-19 | 2019-05-31 | Аптиникс Инк. | Спиролактамовые модуляторы nmda-рецептора и их применение |
| WO2017201285A1 (fr) * | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Modulateurs spirolactames des récepteurs nmda et leurs utilisations |
| WO2019152696A1 (fr) * | 2018-01-31 | 2019-08-08 | Aptinyx Inc. | Spiro-lactame modulateur de récepteurs nmda et leurs utilisations |
| MA56550A (fr) * | 2019-06-24 | 2022-04-27 | Naurex Inc | Formes solides de tert-butyl (s)-2-((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo -2, 5-diazaspiro[3,4]octane-5-carboxylate et leurs procédés de préparation |
| US12215114B2 (en) | 2019-06-24 | 2025-02-04 | Naurex Inc. | Processes and intermediates for producing diazaspiro lactam compounds |
-
2020
- 2020-06-23 US US17/621,905 patent/US12215114B2/en active Active
- 2020-06-23 MA MA056551A patent/MA56551A/fr unknown
- 2020-06-23 TW TW109121351A patent/TWI887245B/zh active
- 2020-06-23 CN CN202080059426.8A patent/CN114269338B/zh active Active
- 2020-06-23 EP EP20832011.9A patent/EP3986400B1/fr active Active
- 2020-06-23 EP EP24195355.3A patent/EP4484431A3/fr active Pending
- 2020-06-23 CN CN202510130487.3A patent/CN120004904A/zh active Pending
- 2020-06-23 ES ES20832011T patent/ES2991258T3/es active Active
- 2020-06-23 WO PCT/US2020/039164 patent/WO2020263848A1/fr not_active Ceased
-
2024
- 2024-12-20 US US18/990,702 patent/US20250243211A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3986400B1 (fr) | 2024-08-21 |
| CN120004904A (zh) | 2025-05-16 |
| EP3986400A4 (fr) | 2023-05-17 |
| US20250243211A1 (en) | 2025-07-31 |
| CN114269338B (zh) | 2025-02-18 |
| CN114269338A (zh) | 2022-04-01 |
| US12215114B2 (en) | 2025-02-04 |
| EP3986400C0 (fr) | 2024-08-21 |
| US20220259217A1 (en) | 2022-08-18 |
| TWI887245B (zh) | 2025-06-21 |
| ES2991258T3 (es) | 2024-12-03 |
| WO2020263848A1 (fr) | 2020-12-30 |
| EP3986400A1 (fr) | 2022-04-27 |
| EP4484431A2 (fr) | 2025-01-01 |
| TW202110852A (zh) | 2021-03-16 |
| EP4484431A3 (fr) | 2025-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53219A (fr) | Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase | |
| EP3652303A4 (fr) | Plate-forme microfluidique pour la production rapide d'organoïdes/sphéroïdes pour criblage de composés | |
| MA54946A (fr) | Procédés et composés | |
| EP3665142A4 (fr) | Procédés à flux continu pour la fabrication de composés bicycliques | |
| MA46791A (fr) | Composés et procédés pour réduire l'expression d'atxn3 | |
| MA50169A (fr) | Procédé de production d'un électrocatalyseur | |
| EP3615657A4 (fr) | Appareil, procédés et composition pour la synthèse de composés cannabinoïdes | |
| EP3897717A4 (fr) | Procédés de production d'anticorps hétérodimères | |
| EP3678700A4 (fr) | Composés pour la réduction de la viscosité de formulations biologiques | |
| EP3611171A4 (fr) | Procédé de synthèse d'éliglustat et de composés intermédiaires de celui-ci | |
| IL285339A (en) | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof | |
| HUE064888T2 (hu) | Eljárás alkoxilátok elõállítására | |
| EP3842522A4 (fr) | Procédé de production de lymphocytes t régulateurs | |
| SG11202010677XA (en) | Methods for the production of methacrylates | |
| EP3889374A4 (fr) | Procédé de construction d'immeubles | |
| EP3648773A4 (fr) | Composés et procédés pour l'administration transmembranaire de molécules | |
| HUE062863T2 (hu) | Eljárás szulfid szilárd elektrolit elõállítására | |
| IL284374A (en) | Methods of producing ustekinumab | |
| IL282387A (en) | Carbonation of fiber cement products | |
| EP3927685A4 (fr) | Procédé de synthèse de composés diamide anthranilique et intermédiaires associés | |
| EP3947409A4 (fr) | Production biosynthétique d'udp-rhamnose | |
| EP3903987A4 (fr) | Procédé d'assemblage | |
| HUE058990T2 (hu) | Folyamatos eljárás trazodon elõállítására | |
| EP3986400A4 (fr) | Procédés et intermédiaires pour la production de composés de diazaspiro-lactame | |
| EP3831804A4 (fr) | Procédé de production de 1-acyloxy-2-méthyl-2-propène |